Journal of Medical Toxicology Edit
Mark Mycyk, MD, FACMT
Cook County Health and Hospitals System
Mark Mycyk found his way to medicine after obtaining a degree in English and American Literature from Harvard University. He completed a residency in emergency medicine at Boston City Hospital/Boston Medical Center, a fellowship in medical toxicology at the Toxikon Consortium and Cook County Hospital in Chicago, and currently serves as the Research Director at the Toxikon Consortium. His current scholarly work focuses on NEW (non-traditional, emerging, and web-based) drugs of abuse and innovative ways of disseminating scholarship.
Howard Greller, MD, FACMT
Icahn School of Medicine at Mount Sinai
New York, NY
Dr. Greller received his BA from Yale University and his MD from the New York University School of Medicine. He completed his residency in Emergency Medicine at the University of Pennsylvania and completed a fellowship in Medical Toxicology at the New York University School of Medicine / New York City Poison Control Center. He served as the Chairman of the ACMT Website Committee for seven years, overseeing the development, design, implementation and transition of the ACMT website (www.acmt.net). He launched the Enduring Education committee, dedicated to the enhancement, preservation and advancement of the educational efforts for the college. He is the moderator and administrator of the Forum of ACMT, the College’s online discussion board. Dr. Greller has served as a member of the Board of Directors of both ACMT and the Medical Toxicology Foundation. He has worked closely with other committee chairs and board members to foster educational goals, such as the Innovative Teaching Award, which is an unrestricted grant for innovations in medical toxicology education. He works closely with the Public Affairs Committee of ACMT, engaging with the public through the “Ask A Toxicologist” program. Dr. Greller’s vision is to “make ACMT, and the information possessed by medical toxicologists, more accessible in the world of medicine.”
Michael Hodgman, MD, FACMT
Upstate New York Poison Center, Syracuse, NY
Michael Hodgman has been a consultant to the Upstate New York Poison Center for 12 years and for the past year has served as Program Director of the newly created Medical Toxicology Fellowship at Upstate Medical University in Syracuse, NY. Much like his experience now with the nascent fellowship program in Syracuse, he was the first fellow to complete a Medical Toxicology Fellowship at the University of Pittsburgh. His interests include critical care toxicology, drugs of abuse and medical education. Outside the workplace, his pursuits include running and cycling.
Leslie Dye, MD, FACMT, ABAM
Wright Sate University
Boonshoft School of Medicine, Dayton, OH
Dr. Leslie Dye is a physician with multiple talents AND personality who loves new endeavors. She is a leader in global digital healthcare content development and delivery who uses my continued clinical expertise and activity. Triple board-certified in emergency medicine, medical toxicology, and addiction medicine, with a deep understanding and national prominence in the field of opioid use disorder. She has academic and business content expertise from my experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal and EIC of physician and pharmacist content production for a leading international medical digital content provider. She has collaborated with multiple digital products and content teams, including those in commercial, informatics, taxonomy, and customer engagement. Her subject matter expertise is demonstrated in my role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer-reviewed publications and 16 textbook chapters, 65 national and 11 international presentations, 10 various commentaries, interviews and podcasts. And my leadership skills have been proven in both corporate and academic environments, as a long-term board member and past president ACMT and as the manager of as many as 30 team members.
Dr. Dye’s clinical skills in addiction medicine and expertise in medical coding continue to be practiced regularly, and my clinical and academic activities have extended globally. She received a grant that enabled me to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over three years in the US. In addition to work, She is extremely active in the community and was nominated as Cincinnati Woman of the year in 2012. She worked as a physician at a free county health clinic for many years and am experienced in providing medical care in remote polar regions with no access to advanced medical facilities.
Jeanmarie Perrone, MD, FACMT
Perelman School of Medicine, University of Pennsylvania
Dr. Perrone is the Director of Medical Toxicology at the Perelman School of Medicine at the University of Pennsylvania and an Attending Physician in an urban academic emergency department where she teaches emergency medicine and medical toxicology. Her research interests have focused on drugs of abuse and more recently on the epidemic of prescription drug abuse. She has lectured nationally and published in NEJM and JAMA on identifying opioid misuse. She is a consultant to both FDA and CDC on methods to track and evaluate concerns regarding prescription opioids.
David Jang, MD, MSc
University of Pennsylvania Perelman School of Medicine
Department of Emergency Medicine
Dr. Jang obtained his MD from Tufts University School of Medicine in 2006. He then completed an emergency medicine residency at the University of Pittsburgh in 2009 followed by a medical toxicology fellowship at the New York University School of Medicine. Upon completion of his medical toxicology fellowship, Dr. Jang obtained his Masters of Science degree in Clinical Investigation with a concentration in translational research from the NYU Clinical and Translational Science Institute. Prior research interest include treatment of shock from cardiovascular drug poisoning investigating agents such as methylene blue and high-insulin therapy in various experimental models. Dr. Jang is currently a NHLBI K12 Research Scholar in Emergency Medicine at the University of Pennsylvania. Dr. Jang’s current research interest is the application of cytoplasmic hybrids (cybrids) to study mitochondrial dysfunction with acquired mitochondrial inhibition specifically focused in the cardiovascular system.
Andis Graudins, MB, BS, PhD, FACEM, FACMT
Southern Clinical School of Monash University
Professor Andis Graudins (MB BS, PhD, FACEM, FACMT) is a Clinical Toxicologist, Emergency Physician and Director of Toxicology Training at Monash Health in Melbourne, Australia. He is also the Director of Emergency Medicine and Clinical Toxicology Research at Monash Health and the Southern Clinical School of Monash University. He has a specific research interests in assessment of novel treatments in cardiovascular drug poisoning and paracetamol poisoning as well as investigation of intranasal analgesia delivery in the ED. Professor Graudins is also a consultant toxicologist with the New South Wales and Victorian Poisons Information Centres.
Jeffrey Suchard, MD, FACMT
Toxicology Case Files
University of California, Irvine School of Medicine
Jeffrey Suchard is a product of the University of California: undergraduate Biochemistry at UC Berkeley, medical school at UCLA, and currently Associate Dean for Basic Science Education at UC Irvine School of Medicine. Jeff completed his Medical Toxicology fellowship at Banner Good Samaritan in Phoenix, Arizona, and is perhaps most recognized in toxicologic circles for organizing the annual ACMT CPC competition.
Daniel Brooks, MD, FACMT
Articles You May Have Missed
Banner Good Samaritan Medical Center
Dan Brooks trained in Emergency Medicine (University of Pittsburgh) and then completed a medical toxicology fellowship (in Phoenix). Since then, he has served as Medical Director for 3 different poison centers over the past 10 years. His clinical practice focuses on the acute care of poisoned patients. He is also active in his department’s clinic and outpatient evaluation services. When not working, he can be found throughout Phoenix chasing his wife on single-track or running trails.
Lewis S. Nelson, MD, FACMT
Rutgers New Jersey Medical School
Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine, Chief of Service of the University Hospital Emergency Department, and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School, all in Newark, NJ. He is a Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is Past-President of the American College of Medical Toxicology and a member of the Board of Directors of the American Board of Emergency Medicine. He is an editor of Goldfrank’s Toxicologic Emergencies, currently in its 11th edition
Peter Chai, MD, FACMT
Social Media & Emerging Technologies
Brigham & Women’s Hospital, Boston, MA
Dr. Peter R Chai is an Assistant Professor of Emergency Medicine and Medical Toxicology at Brigham and Women’s Hospital/Harvard Medical School and affiliate research scholar at the Fenway Institute and the Massachusetts Institute of Technology. He is also the site fellowship director for the Harvard Combined Fellowship in Medical Toxicology and practices clinically at Brigham and Women’s Hospital and Faulkner Hospital. He is interested in the development of technologies to detect changes in human health with a focus in medication adherence for HIV prevention and is the recipient of independent research grants from Gilead Sciences as well as the National Institute on Drug Abuse to investigate the use of real-time adherence monitoring using ingestible sensors to measure Pre-exposure Prophylaxis for HIV using once daily Emitricitabine/Tenofovir. His interest in ingestible electronics leads to collaborations at the Massachusetts Institute of Technology where he is an affiliate research scholar to develop next generation long term ingestible sensors and drug delivery packages surrounding HIV prevention and substance use disorder treatment. He additionally collaborates with the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School on and ethical implications and health law policy surrounding electronic adherence monitoring.
Wilson Rumbeiha, BVM, PhD, DABVT, DABT
Iowa State University
Wilson Rumbeiha is the Editor of the Veterinary Toxicology Section for JMT. Dr Rumbeiha is a 1982 graduate of Makerere University, Kampala Uganda (BVM) and of the Ontario Veterinary College, University of Guelph, Guelph, Ontario Canada in 1991 (PhD). After a completing a Residency/Post doc at Kansas State University in 1993, Dr Rumbeiha joined Industry, where he served as Staff Scientist at Embro Corporation in Minneapolis, MN, and then Study Director, Comparative Toxicology Division, White Sands Research Center, Alamogordo, NM.
Following a short stint in industry Dr Rumbeiha worked as a Clinical Toxicologist at Michigan State University from January 1996 to August 2011where he rose from the rank of Assistant Professor to Associate Professor, in the Department of Pathobiology and Diagnostic Investigation. He also served as the Section Chief of Toxicology in the Diagnostic Center for Population and Animal Health, at the same time. In August 2011 Dr Rumbeiha joined Iowa State University where he is currently serving as a Professor of Veterinary Toxicology in the Department of Veterinary Diagnostic and Production Animal Medicine (VDPAM). He is Board-certified both by the American Board of Toxicology (ABT) and by the American Board of Veterinary Toxicology (ABVT). He has held and continues to serve in various professional leadership positions.
Mark Su, MD, MPH
Senior Statistical Editor
New York University School of Medicine
New York, NY
Mark is currently the Director of the New York City Poison Control Center an attending physician in the NYU/Bellevue Hospital Center Emergency Department. His a graduate of the State University of New York Downstate Medical Center and Columbia University Mailman School of Public Health. He completed his Emergency Medicine training at SUNY-Downstate Medical Center/Kings County Hospital Center in Brooklyn, NY and Fellowship Training in Medical Toxicology at the New York City Poison Control Center. His current research interests focus mostly on synthetic cannabinoids and the epidemiology of poisoning
Trevonne Thompson, MD, FACMT
Fellow-in-Training (FIT) Program
University of Illinois Hospital & Health Sciences System
Trevonne Thompson attended Xavier University of Louisiana in New Orleans followed by medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He completed his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County) and fellowship at the Toxikon Consortium Medical Toxicology Fellowship in Chicago. He is currently an emergency physician and medical toxicologist at the University of Illinois Hospital & Health Sciences System, where he leads the medical toxicology consultation service. He is an assistant professor of emergency medicine and medical toxicology at the University of Illinois at Chicago and is the associate director of the Division of Medical Toxicology within the Department of Emergency Medicine. He is a faculty member of the Toxikon Consortium and works closely with the Illinois Poison Center.
Maryann Amirshahi, PharmD, MD, MPH, FACMT
MedStar Washington Hospital Center, Children’s National Medical Center
Dr. Amirshahi completed her BS in pharmacy and PharmD at the University of the Sciences in Philadelphia, followed by medical school at Temple University. She completed emergency medicine residency at the University of Pennsylvania, medical toxicology fellowship at the George Washington University, and clinical pharmacology fellowship at Children’s National Medical Center. She received an MPH from the George Washington University with a concentration on environmental and occupational health. She is board certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology. She is currently an Associate Professor of Emergency Medicine at the Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center and Children’s National Medical Center in Washington, DC. She serves as a toxicology consultant for the Mid-Atlantic Center for Children’s Health and the Environment and the National Capital Poison Center. Her research interests focus on medication safety, prescription drug shortages, drug therapy in emergency medicine, and prescription drug abuse.
Gillian Beauchamp, MD
Lehigh Valley Health Network, Department of Emergency and Hospital Medicine
Dr. Beauchamp is a member of the toxicology faculty and Assistant Director of Research in Medical Toxicology at Lehigh Valley Health Network Department of Emergency and Hospital Medicine, Section of Medical Toxicology. She is an assistant professor at University of South Florida Morsani College of Medicine. She is board certified in emergency medicine, medical toxicology, and addiction medicine. Gillian leads online education for ACMT. Her research and administrative areas of focus are opioid stewardship and linkage to treatment/medication assisted treatment for substance use disorder.
Andrew Chambers, MD
Virginia Commonwealth University
Andrew Chambers graduated from Stonehill College with a BS in Neuroscience and then attended New York College of Osteopathic Medicine in Long Island, New York. From there, he completed his Emergency Medicine residency at Penn State Health in Hershey, PA. He is currently a medical toxicology fellow at Virginia Commonwealth University in Richmond, VA.
Eric Lavonas, MD, FACMT
Rocky Mountain Poison and Drug Center
Eric Lavonas is Associate Director and fellowship Program Director at the Rocky Mountain Poison and Drug Center in Denver. A native of upstate New York, he completed emergency medicine residency at Methodist Hospital of Indiana and medical toxicology fellowship at Carolinas Medical Center. His research interests include antivenoms, carbon monoxide poisoning, clinical trials, and cost-quality relationships in hospital pharmacy operations. When not at work, he can be found chasing his children through the great Colorado outdoors.
Michael Levine, MD, FACMT
University of Southern California
Los Angeles, CA
Michael Levine completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine Residency, based out of Brigham and Women’s/Massachusetts General Hospital. He subsequently completed his training and medical toxicology at the Banner Good Samaritan Medical Center in Phoenix, Arizona before joining the faculty in there. He later moved to Los Angeles, California where he was the division chief of medical toxicology at the University Southern California. In 2020, Dr. Levine moved to University of California Los Angeles (UCLA) where he is an emergency physician and in charge of the in patient and out patient toxicology services. He lives in Los Angeles with his wife and children.
Natalie Neumann, MD
Department of Emergency Medicine, Yale School of Medicine
Natalie Neumann is an attending of emergency medicine and toxicology in the Department of Emergency Medicine at the Yale School of Medicine. She also attends the Rocky Mountain Poison and Drug Safety where she completed her fellowship. Her research interests involve the intersection of global health and toxicology. She is especially interested in research that examines the efficacy, pharmacology, and toxicity of traditional herbal therapies.
Katherine O’Donnell, MD
Boston Children’s Hospital, Harvard Medical School
Katie O’Donnell is a pediatric toxicologist and hospitalist at Boston Children’s Hospital and serves as a consultant to the MA/RI Regional Center for Poison Control and Prevention. She is board certified in general pediatrics, medical toxicology, and pediatric hospital medicine. She serves as the Undergraduate Medical Education Director at Boston Children’s Hospital and as the Pediatric Clerkship Director at Harvard Medical School. Her interests include pediatric toxicology, medication safety, efforts to recruit more pediatricians into the field of toxicology, and medical education.
Meghan Spyres, MD
University of Arizona College of Medicine Phoenix; Department of Medical Toxicology, Banner University Medical Center Phoenix,
Dr. Spyres received her MD from Columbia University College of Physicians and Surgeons in New York City and stayed in New York to complete an Emergency Medicine residency at Bellevue/New York University. She completed her Medical Toxicology fellowship training in 2016 at Banner—University Medical Center in Phoenix, Arizona. She is currently Associate Professor of Clinical Emergency Medicine at the University of Arizona College of Medicine Phoenix and faculty in the department of Medical Toxicology at Banner—University Medical Center Phoenix. Her research interests include envenomations, emerging drugs of abuse, gender in medicine, and the intersection of critical care and toxicology. She is co-founder of Women in Toxicology, a subgroup of ACMT that promotes women in academic medicine. Additionally, she is part the leadership team for ACMT’s Toxicology Investigators Consortium Registry (ToxIC), focusing on detecting trends in novel drugs.
Milton Tenenbein, MD, FACMT
University of Manitoba, Children’s Hospital
Dr. Tenenbein is a practicing pediatrician and toxicologist at the Children’s Hospital in Winnipeg Manitoba. He is currently a Professor of Pediatrics, Pharmacology, Internal Medicine and of Community Health Sciences at the University of Manitoba. In the past he served as the Director of Emergency Services at Children’s Hospital and as the Director of the Manitoba Poison Control Centre for over three decades.
Dr. Tenenbein graduated from the University of Manitoba, Faculty of Medicine in 1973. He did his pediatric residency at Children’s Hospital in Winnipeg and at the Isaack Walton Killam Hospital in Halifax, Nova Scotia.
He obtained certification in Pediatrics from the Royal College of Physicians and Surgeons of Canada and in Toxicology from the American Board of Medical Toxicology. He began his practice of Pediatric Emergency Medicine in 1977 and is one of the founders of that sub-spe
Richard Wang, MD, FACMT
National Center for Environmental Health, Centers for Disease Control and Prevention
Richard Wang is a medical officer at the Division of Laboratory Sciences / National Center for Environmental Health, Centers for Disease Control and Prevention. He received his medical degree from New York College of Osteopathic Medicine, Old Westbury, NY, and completed residency training in emergency medicine at Michigan State University, Lansing, MI. Dr. Wang went on to complete a fellowship in medical toxicology at Bellevue Medical Center, New York University School of Medicine and New York City Poison Control Center, New York, NY. He is board certified in emergency medicine and medical toxicology.
Dr. Wang provides medical interpretation of biomonitoring data, and consultation with others in the field to enhance the understanding of human toxicology. Dr. Wang served as the principal investigator for the U.S. component of the Third World Health Organization-Coordinated Survey of Human Milk for Persistent Organic Pollutants and for studies on sampling and analytical detection of environmental chemicals in human milk, the distribution of chemicals from blood into milk, and the concentration of selected chemicals in unique populations. In addition, he participates on several national and federal committees and working groups, and serves as the chairperson of the Division of Laboratory Sciences Safety Committee at CDC.
Dr. Wang received the U.S. Department of Health and Human Services Secretary’s Award for Distinguished Service for his responses to the World Trade Center event and Hurricanes Katrina, Rita, and Wilma. He is a past Chair of Toxicology Section of American College of Emergency Physicians and has been named a Fellow of the American College of Emergency Physicians and of the American College of Medical Toxicology.
Ashley Webb, MSc, PharmD
Kentucky Poison Control Center; University of Kentucky School of Pharmacy; University of Louisville Department of Emergency Medicine
Ashley Webb completed a Master’s of Science Degree in Cellular Biology prior to completing her PharmD at Wingate University. She further completed an Emergency Medicine Toxicology Pharmacy Residency at Carolinas Medical Center through the North Carolina Poison Control Center in 2009. She is a board-certified by the American Board of Applied Toxicology (ABAT) and an active member of the AAPCC, AACT, and an affiliate member of ACMT. Dr. Webb served as an assistant professor at SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences where she developed a clinical pharmacy toxicology consulting service at Erie County Medical Center and served as a preceptor for both pharmacy students and residents as well as emergency medicine residents. In 2013, Dr. Webb took over as the director of the Kentucky Poison Control Center. In addition to the poison control center hotline, she also oversees the state 24 hour HIV hotline and Opioid Assistance and Resources Hotline. She currently precepts pharmacy students and residents and hosts medical students for education in clinical toxicology and she holds adjunct faculty positions from the University of Kentucky, University of Louisville, and Sullivan College of Pharmacy.
Anselm Wong, MBBS DipTox, PhD, FACEM, FAACT, FACMT
Anselm Wong is a medical toxicologist and emergency physician at Austin Health in Victoria, Australia. He is a consultant with the Victorian Poisons Information Centre. He is the medical lead for toxicology research at his institute and is the current Chair of the Toxicology and Poisons Network Australasia Scientific Committee. He is the director of the Global Educational Toxicology Uniting Project (GETUP), ACMT. Current research interests include risk prediction and management of acetaminophen poisoning, and participation in clinical toxicology collaborative guideline workgroups.
David Wood, BSc, MB ChB, MD, FRCP, FBPharmacolS, FACMT
King’s College London
Dr. David Wood has been a Consultant Physician and Clinical Toxicologist at Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK since 2007. He trained at the University of Bristol graduating with honors in 1997, and then after initial postgraduate training undertook joint specialist training in general (internal) medicine and clinical pharmacology and therapeutics with a specialist interest in clinical toxicology. His specialist clinical and research interest is in the field of recreational drugs and novel psychoactive substances (“legal highs”), particularly in the epidemiology of their use and the associated acute toxicity. He is an expert adviser to the UK Advisory Council on the Misuse of Drugs (ACMD) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in these areas. He has published 25 peer-reviewed reviews and editorials and 86 peer-reviewed scientific papers, and has given numerous invited keynote lectures at both clinical toxicology and other medical/scientific conferences.
JMT Advisory Board
Charles McKay, MD, FACMT (Hartford, CT)
Anne-Michelle Ruha, MD, FACMT (Phoenix, AZ)
JMT Past Editor-in-Chiefs
Leslie R. Dye, MD, FACMT
Chris Tomaszewski, MD, FACMT
Kevin Osterhoudt, MD, FACMT
President: Louise Kao, MD, FACMT
Vice-President: Anthony Pizon, MD, FACMT
Secretary/Treasurer: Ziad Kazzi, MD, FACMT
Past-President: Michelle Ruha, MD, FACMT
2021-2022: George Warpinski, MD – Banner University Medical Center, Phoenix, AZ
2020-2021: Jennifer Ross, MD, MPH – University of Virginia, Blue Ridge Poison Center, Charlottesville, VA
2019-2020: Michael Chary, MD – Boston Children’s Hospital, Boston, MA
Natalie Neumann, MD – Rocky Mountain Poison and Drug Safety, Denver, CO
2018-2019: Daniel McCabe, MD – Regions Hospital & Minnesota Poison Control, St. Paul, MN
2017-2018: Jaiva Larsen, MD – University of Arizona, Tucson, AZ
2016-2017: Rachel Wightman, MD – New York University/Bellevue, New York, NY
2015-2016: Gillian Beauchamp, MD – Oregon Health and Science University, Portland, OR
Peter Chai, MD – University of Massachusetts, Worcester, MA
2014-2015: Rebecca Bruccoleri, MD – Harvard Medical Toxicology Fellowship, Boston, MA
2013-2014: Navneet Cheema, MD – Toxikon Consortium, Chicago, IL
Mark Neavyn, MD – University of Massachusetts, Worcester, MA
2012-2013: Patrick Lank, MD – Toxikon Consortium, Chicago, IL
Aaron Skolnik, MD – Banner Health, Phoenix, AZ
2011-2012: Christine Murphy, MD – Carolinas Medical Center, Charlotte, NC
2010-2011: David Jang, MD – New York University/Bellevue, New York, NY